ARTICLE
Top Takeaways | Specialty Spotlight: Orthopedics/Physical Therapy
May 26, 2023
Read time: 3 min
In this session, Patrick Zanayad, a partner in McDermott’s Healthcare practice group, moderated a panel of senior healthcare executives that featured a wide-ranging discussion of the current state of orthopedics and physical therapy (PT) and explored what’s coming next in this important specialty.
Session panelists included:
- Charles Davis, Managing Partner, MD Healthcare Partners
- Thomas Dwyer, MD, President, Premier Orthopaedic Associates (part of American Orthopedic Partners)
- Emil Engels, MD, Chief Executive Officer, Aligned Orthopedic Partners
- Keith Lockwood, ManagingDirector, Jefferies & Company
Top takeaways included:
- Income repair in orthopedic platforms can be achieved through multiple avenues, including, among others, by fostering ancillary growth, introducing surgery-center ownership, negotiating better managed-care contracts, entering unique partnerships with entities and participating in integrated networks.
- As value-based care (VBC) continues to grow in the healthcare industry, orthopedic platforms with capital support are better positioned than smaller, independent practices to participate in VBC due to the larger entities’ greater access to quality patient data, particularly given the costs associated with gathering such data. Further, orthopedics, unlike other specialties, has an advantage in VBC models since such practices tend to have more control over a patient’s full care journey and costs. For example, certain orthopedic platforms include practices with urgent-care centers that promote the practice’s ability to capture a patient’s entire spectrum of care, including surgical procedures and post-op physical therapy.
- Orthopedic platforms can promote vertical growth through a number of pathways, including, among others, by adding new physicians and developing ancillary streams of revenue such as diagnostic imaging, physical therapy, and other services that address an orthopedic patient’s full spectrum of care.

Top Takeaways | Specialty Spotlight: Women’s Health and Fertility
ARTICLE
Top Takeaways | Specialty Spotlight: Women’s Health and Fertility
May 26, 2023
Read time: 3 min
In this session, Brian Hall, a partner in McDermott’s Healthcare practice group, moderated a panel to discuss the opportunities for growth and investment in the women’s health and fertility space.
Session panelists included:
- Andrew Colbert, Senior Managing Director, Ziegler
- Eleanor Harte, Chief Operating Officer, Colorado Center for Reproductive Medicine
- Erica Pham, General Counsel, Maven Clinic
- Cara Reymann, Chief Executive Officer, Fertilitas
- Maxine Winston, Interim Chief Development Officer, Axia Women’s Health
Top takeaways included:
- The women’s health market continues to be very fragmented, with most obstetrics and gynecology (OB/GYN) and fertility providers practicing as members of small groups. The vast majority of OB/GYN practices are comprised of one to three physicians, while there are approximately 500 fertility clinics total in the United States.
- There is a strong value-based care (VBC) opportunity in the women’s health space, with payors looking to partner more with OB/GYNs on bundled payment models.
- Investors view women’s health and OB/GYN clinics as an offshoot of primary care, which offers numerous opportunities to leverage OB/GYN services as the epicenter for primary care for women.
- Since the US Supreme Court’s decision in Dobbs, overturning Roe v. Wade, the famous phrase “healthcare is local” is being questioned. More employers are now incorporating the ability to travel for care into their insurance coverage offered to employees. It is the first time that companies must rethink how and where they are offering care.
- The women’s health space is expected to face a decrease in the number of providers coming out of fellowships, yet patient demand is anticipated to grow exponentially. According to the US Health Resources & Services Administration (HRSA), the demand for OB/GYNs is expected to increase 4% by 2030. However, the number of OB/GYNs is expected to decrease by 7%. Fertility is facing a similar trend, making it important for operators to have a sound recruitment and growth strategy to meet patient demand.
- Three strategies for addressing the labor issues in the women’s health space are: (1) leveraging the use of advanced practitioners, such as nurse practitioners and physicians assistants, so that physicians can extend themselves and see more patients, (2) being at the forefront of recruiting by developing relationships with residency programs, and (3) doing everything possible to support the physicians by creating the right culture, incentives for physicians to stay longer with the practice, and new growth opportunities.

Congress Adds AKS and Stark Law Exceptions for Certain Wellness Programs
ARTICLE / CLIENT ALERT
Congress Adds AKS and Stark Law Exceptions for Certain Wellness Programs
May 25, 2023
Read time: 5 min
As a part of the Consolidated Appropriations Act, 2023 (CAA), Congress passed new exceptions to the Physician Self-Referral Law (Stark Law) and the federal Anti-Kickback Statute (AKS) allowing certain healthcare entities to provide mental health or behavioral health improvement and/or maintenance programs to physicians and other clinicians.
The Stark Law prohibits physicians from referring patients for certain designated health services payable by Medicare to an entity with which the physician (or an immediate family member) has a financial relationship, unless an exception applies, and prohibits such entities from filing claims with Medicare for the referred designated health services. Similarly, the AKS makes it a crime for any person to knowingly and willfully offer, pay, solicit or receive any remuneration to induce a person to make referrals for items or services that may be covered by Medicare or another federal healthcare program. Absent a statutory or regulatory exception or safe harbor, healthcare entities are subject to risks under the AKS and Stark Law when providing free services to physicians or clinicians that refer patients to the entity.
The new exceptions under the CAA apply to wellness programs offered on or after December 29, 2022.
Stark Wellness Program Exception
The CAA included a new compensation arrangement exception to the Stark Law for physician wellness programs. This Stark wellness program exception is codified at 42 U.S.C. 1395nn(e)(9). To date, the US Department of Health and Human Services (HHS) has not promulgated regulations further implementing the statutory changes.
To qualify for the Stark wellness program exception, the arrangement must be for a bona fide mental health or behavioral health improvement or maintenance program offered to a physician by an entity. The program must meet the following requirements:
- Consist of counseling, mental health services, a suicide prevention program, or a substance use disorder prevention and treatment program
- Be made available to a physician for the primary purpose of preventing suicide, improving mental health and resiliency, or providing training in appropriate strategies to promote the mental health and resiliency of the physician
- Be set out in a written policy, approved in advance of the program’s operation by the governing body providing the program, that includes at minimum a description of the content and duration of the program, a description of the evidence-based support for the design of the program, the estimated cost of the program, the personnel (including the qualifications of such personnel) conducting the program, and the method by which the entity will evaluate the use and success of the program, all of which must be updated in advance of substantial changes to the operation of the program
- Be offered by an entity described below with a formal medical staff to all physicians who practice in the geographic area served by such entity, including physicians who hold bona fide appointments to the medical staff of such entity or otherwise have clinical privileges at such entity
- Be offered to all such physicians on the same terms and conditions and without regard to the volume or value of referrals or other business generated by a physician for the entity
- Be evidence-based and conducted by a qualified health professional
- Meet any other regulatory requirements that may be imposed by the HHS Secretary through regulation.
The Stark wellness program exception is not available to all healthcare entities. Entities that are eligible to avail themselves of the Stark wellness program exception include hospitals, ambulatory surgical centers, community health centers, rural emergency hospitals, rural health clinics, skilled nursing facilities or similar entities, as determined by the HHS Secretary.
The Stark wellness program exception also requires that neither the provisions nor the value of the program be contingent upon the number or value of referrals made by a physician to the entity, or the amount or value of the other business generated by such physician for the entity.
AKS Wellness Program Exception
The CAA included similar amendments to the AKS, creating an exception for bona fide mental health or behavioral health improvement or maintenance programs.
The AKS wellness program exception largely matches the language and program types set out in the Stark wellness program exception but includes clinicians in addition to physicians. Oddly, the AKS wellness program exception does not explicitly include rural health clinics. Since operation within a safe harbor is not required for AKS compliance, however, a program offered by a rural health clinic that complies with all other requirements of the AKS wellness program exception would seem unlikely to violate the AKS, absent an intention to induce referrals.
Key Takeaways
- The Stark and AKS wellness program exceptions provide a new avenue for qualified entities to provide additional mental and behavioral health resources to healthcare professionals at a time when burnout and other mental health concerns continue to rise among healthcare providers.
- Entities seeking to structure a compliant wellness program should carefully evaluate each of the required components of the wellness program exceptions to avoid technical foot faults and unintentional non-compliance.
- As more entities begin to avail themselves of the new wellness program exceptions, parties to potential transactions with eligible entities should inquire about such programs in due diligence and make sure such programs comply with the applicable requirements.

Texas Approves SB 14 Prohibiting Gender-Affirming Care for Minors
ARTICLE / CLIENT ALERT
Texas Approves SB 14 Prohibiting Gender-Affirming Care for Minors
May 25, 2023
Read time: 6 min
On May 17, 2023, the Texas Senate approved Senate Bill No. 14 (SB 14), prohibiting physicians from providing gender-affirming medical care to minors experiencing gender dysphoria (distress that results from having one’s gender identity not match one’s sex assigned at birth). The bill is expected to be signed into law by Texas Governor Greg Abbott and take effect on September 1, 2023.
SB 14 prohibits physicians and other licensed medical professionals from performing certain procedures and providing certain treatments to patients younger than 18 years of age “for gender transitioning, gender reassignment, or gender dysphoria.” SB 14 prohibits puberty blockers, hormone therapy that induces transient or permanent infertility, sterilization surgeries, mastectomies, and the removal of any otherwise healthy or non-diseased body part or tissue for the purpose of transitioning a child’s biological sex. The bill also prohibits the “use of public money or public assistance” to provide such treatments, and it further prohibits Medicaid and child health plan reimbursement for these treatments. The Texas Medical Board is directed to revoke the licenses of medical professionals who provide such services.
The bill does not prohibit puberty suppressants or certain medically necessary procedures for the treatment of premature puberty, and it does not prohibit treatments to children who were born with a medically verifiable genetic disorder of sex development or to children who do not have male or female sex chromosome structures as determined through genetic testing by a physician. SB 14 also includes a limited exception for minors receiving treatment prior to the bill’s passage. However, it requires those individuals to “wean” off the medications in a “safe and medically appropriate” manner, and they may not switch to or begin a course of treatment on another prescription drug that is otherwise prohibited by SB 14.
The bill enables the Texas attorney general to enforce the prohibition on gender-affirming care for minors by bringing an action to restrain or enjoin a person from committing, continuing to commit or repeating the violation. The Texas attorney general can initiate enforcement actions if the attorney general “has reason to believe that a person is committing, has committed, or is about to commit” a violation.
SB 14 comes on the heels of a legal opinion released by the Texas Office of the Attorney General (OAG) on February 18, 2022, classifying certain gender-affirming services as child abuse under various sections of the Texas Family Code. The OAG qualified such treatment as child abuse on the basis that it causes “mental or emotional injury to a child that results in an observable and material impairment in the child’s growth, development, or psychological functioning” under Texas Family Code § 261. Governor Abbott stated in a subsequent directive that medical professionals who facilitate access to these services and individuals who have mandatory reporting obligations but fail to report violations are subject to criminal penalties.
On May 5, 2023, the OAG launched an investigation into Dell Children’s Medical Center in Austin to uncover whether the center had performed gender transitioning procedures. A group of physicians who staffed the adolescent medicine clinic have since departed, although the clinic has not shut down. On May 19, 2023, the OAG launched a similar investigation into Houston-based Texas Children’s Hospital. Both investigations were initiated pursuant to the OAG’s “power and duty to protect and enforce the public interest in nonprofit organizations” and required the production of various documents and communications pertaining to the facilities’ provision of gender-affirming care.
Key Takeaways and Practical Implications
- In passing SB 14, Texas joins a growing number of states that have enacted similar restrictions on medical treatments for transgender minors. SB 14 prohibits medical professionals from providing gender-affirming care to minors, prohibits the use of public money to provide such treatments, and prohibits Medicaid and child health plan reimbursement for these services.
- SB 14 is expected to directly impact medical professionals who provide gender-related care to minors. Providers and healthcare facilities should expect robust enforcement efforts by state officials, as signaled by the investigations into Dell Children’s Medical Center and Texas Children’s Hospital initiated even prior to the law’s enactment. The bill’s provision allowing enforcement if the Texas attorney general “has reason to believe” that a person not only “is committing” or “has committed” a violation, but also “is about to commit” a violation, further signals that aggressive enforcement measures will be taken.
- SB 14 is likely to be challenged in the courts, as several organizations have already stated that they intend to file a lawsuit challenging the legislation. Although court decisions may pause the law’s enforcement or limit its application, Texas is likely to appeal such decisions. As a result, court battles are likely to be lengthy and create significant uncertainty for healthcare providers and transgender minors in Texas.
- As the Dell Children’s and Texas Children’s investigations indicate, adolescent providers can expect to be under increased scrutiny regarding care provided to minors. Providers should reevaluate their documentation practices and ensure that for any of the prohibited services provided, where an exception applies (such as precocious puberty or a verifiable disorder of sex development), that exception is carefully and consistently documented in the medical file.
- Further legislation in other states is extremely likely, and that legislation could result in a wide variety of restrictions that would impact any risk analysis. In light of such uncertainties, organizations should stay in close touch with knowledgeable legal counsel to decide how to manage their conduct going forward, particularly if they intend to provide or facilitate access to gender-affirming care, or any medical care to minors who may be experiencing gender dysphoria. Legal planning should take into account privacy, healthcare regulatory, subpoena response and litigation/enforcement defense considerations.
- Providers and facilities are encouraged to involve in-house or outside legal counsel directly in planning discussions so they are protected by the attorney-client privilege as much as possible. Providers and facilities must be thoughtful about any public or internal statements on the matter.
Our multidisciplinary team of healthcare, privacy, litigation and white collar lawyers is monitoring this legislation and similar legislation in other states. Please do not hesitate to contact the authors or another McDermott contact with regard to any questions on this Texas legislation or related enforcement activity.

Standstill agreements for special real estate funds
ARTICLE / CLIENT ALERT
Standstill agreements for special real estate funds
May 25, 2023
Read time: 2 min
With increasing interest rates and real estate markets facing a difficult time, redemptions of shares in open-ended institutional real estate funds are more likely. One way to restore trust between investors are so called stay-put agreements, stating that investors will not return any shares within a defined time frame. The parties of such an agreement may vary, as well as its binding effect and legal consequences. The following article gives an overview on possible details and aspects that should be considered when drafting the agreement.
Read the full client alert, “Stillhaltevereinbarungen bei Immobilien-Spezialfonds,” in German.

SEC Enforcement Director Highlights Focus on Private Funds
ARTICLE / CLIENT ALERT
SEC Enforcement Director Highlights Focus on Private Funds
May 25, 2023
Read time: 3 min
In a series of recent industry events, U.S. Securities and Exchange Commission (“SEC”) Enforcement Director Gurbir Grewal continued to emphasize that the private funds industry is “a substantive priority area” for the SEC’s enforcement agenda. Director Grewal’s statements are consistent with the significant uptick we have observed in the examination and investigation of private funds and associated individuals.
In his public comments, Director Grewal identified several areas of particular enforcement focus:
- Fees and Expenses
- Conflicts of Interest
- Insider Trading
- Digital Assets
While none of these issues is particularly surprising or novel, the current enforcement focus on them is noteworthy, as is the Director’s willingness to publicly acknowledge this attention. The Commission has been charging firms for improper fee and expense charges for many years, but the issue has again come to the fore with the impending Private Funds Rule[1], which is expected to impose prescriptive mandates on disclosures of fees and expenses. With respect to conflicts of interest, as many private fund businesses have grown in scale and complexity, the potential for conflicts of interest has increased exponentially. Insider trading is a perennial area of focus for the Commission, and an enhanced capacity to surveil trading data has generated increasingly sophisticated techniques for the review and investigation of suspicious or anomalous trading. Finally, as to digital assets, the SEC’s enforcement efforts increasingly focus on gatekeepers or intermediaries – such as unregistered exchanges – that promote or facilitate trading in digital assets that the Commission generally views as unregistered securities.
Director Grewal also made two noteworthy comments about the agency’s focus on “off channel” communications: (1) that the problem is “pervasive”; and (2) that two brokerage firms that recently self-reported significant off-channel communications paid less in penalties than firms that did not self-report.
With increased examination and enforcement activity, and an unprecedented amount of new rulemaking, the private funds industry is very much in focus at the SEC. Well-informed and sophisticated efforts to address these and other issues are particularly important in this context.
Authored by Charles J. Clark, Marc E. Elovitz, Kelly Koscuiszka and Craig S. Warkol.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] /insights/sec-proposes-new-rules-for-private-fund-managers
/media/srz-comments-on-proposed-rules-for-private-fund-advisers-and/
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2023 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

HHS Releases Ownership Data of Medicare-Certified Hospices and Home Health Agencies
ARTICLE / CLIENT ALERT
HHS Releases Ownership Data of Medicare-Certified Hospices and Home Health Agencies
May 24, 2023
Read time: 3 min
On April 20, 2023, the US Department of Health and Human Services (HHS) made ownership data of all Medicare-certified hospices and home health agencies publicly available for the first time. This move is consistent with the Biden administration’s intention to provide greater transparency and accountability in the healthcare industry.
Background
The Biden administration has repeatedly voiced concerns about the lack of transparency and accountability in the healthcare industry and has taken steps to remedy these issues through prior data releases of ownership information. In April 2022, the Centers for Medicare & Medicaid Services (CMS) released data on mergers, acquisitions, consolidations and changes of ownership from 2016–2022 for hospitals and nursing homes enrolled in Medicare; in September 2022, CMS released ownership data on 15,000 skilled nursing facilities; and in December 2022, CMS released ownership information of more than 7,000 hospitals.
According to HHS Secretary Xavier Becerra, this latest action by HHS is intended to “promote competition and protect consumers” and includes detailed information for more than 6,000 hospices and 11,000 home health agencies, including the following:
- Medicare enrollment data such as organization name, type, practice addresses, National Provider Identifier (NPI) number and CMS Certification Number (CCN)
- Information about individual versus organizational owners and whether the ownership interest is direct or indirect
- Numerical associate ID for each owner to enable linkage to the enrollment file
- Data since 2016 regarding mergers, acquisitions, consolidations and changes of ownership experienced by Medicare-enrolled hospices and home health agencies
CMS believes that making this data publicly available will assist CMS and other regulators in
- Holding accountable those hospices and home health agencies that have a pattern of poor performance,
- Providing insight on how market conditions impact consumer costs and quality of care
- Informing policy decisions on competition in healthcare
- Giving consumers more confidence in the decision-making process when choosing which hospices and home health agencies to utilize
It is expected that CMS will release updates to this data on a quarterly basis. Hospices and home health agencies should monitor these updates for accuracy and correct any errors in their enrollment records through PECOS or CMS 855A submissions.

Keeping “Fair Use” Fair: SCOTUS Says First Fair Use Factor Should Be Interpreted Narrowly to Protect Copyright Holders
ARTICLE / CLIENT ALERT
Keeping “Fair Use” Fair: SCOTUS Says First Fair Use Factor Should Be Interpreted Narrowly to Protect Copyright Holders
May 24, 2023
Read time: 8 min
The Supreme Court of the United States affirmed the US Court of Appeals for the Second Circuit’s decision, holding that the first factor in the fair use analysis favored photographer Lynn Goldsmith because the “purpose and character” of Andy Warhol’s pop art rendition was not sufficiently different from that of Goldsmith’s photograph on which Warhol’s work was based. The Andy Warhol Foundation for the Visual Arts, Inc. v. Lynn Goldsmith, et al., Case No. 21-869 (Supr. Ct., May 18, 2023). Justice Sonia Sotomayor delivered the opinion of the Supreme Court, in which Justices Clarence Thomas, Samuel Alito, Neil Gorsuch, Brett Kavanaugh, Amy Coney Barrett and Ketanji Brown Jackson joined. Justice Gorsuch issued a concurring opinion joined by Justice Jackson. Justice Elena Kagan, joined by Chief Justice John Roberts, issued a dissenting opinion.
BACKGROUND
In 1984, Vanity Fair licensed a photograph of the famous musician Prince taken by Lynn Goldsmith for use as an “artist reference for an illustration.” Andy Warhol, the artist hired by Vanity Fair to create the illustration, used Goldsmith’s black and white photograph to create a silkscreen portrait that appeared alongside an article about Prince in the November 1984 issue. Pursuant to the license, which also stipulated that the photograph be used “one time” only, Goldsmith received a $400 fee and was credited for her “source photograph.”
Warhol thereafter created a series of 15 works all based on Goldsmith’s photograph (the Prince Series). Goldsmith was unaware of Warhol’s additional works until 2016, when, upon Prince’s death, Vanity Fair’s parent company licensed one of Warhol’s additional works (referred to as Orange Prince) from The Andy Warhol Foundation for the Visual Arts, Inc. (AWF) for use with an article commemorating Prince’s life. Goldsmith did not enter into a new license, nor did she receive payment or attribution. AWF received $10,000.
When Goldsmith contacted AWF regarding the suspected copyright infringement, AWF sued for declaratory judgment of noninfringement or, alternatively, fair use. The district court granted summary judgment for AWF, finding Orange Prince was protected fair use as the work transformed Goldsmith’s photograph. The district court explained that “the works ‘can reasonably be perceived to have transformed Prince from a vulnerable, uncomfortable person to an iconic, larger-than-life figure,’ such that ‘each Prince Series work is immediately recognizable as a ‘Warhol’ rather than as a photograph of Prince.’”
The Second Circuit, however, reversed and remanded, finding that all four fair use factors favored Goldsmith and noting with respect to the first fair use factor (the purpose and character of the work) that “transformative purpose and character must, at a bare minimum, comprise something more than the imposition of another artist’s style on the primary work.” AWF appealed.
OPINION OF THE SUPREME COURT
The Supreme Court considered only whether Warhol’s Orange Prince made “fair use” of Goldsmith’s photograph. AWF did not appeal the Second Circuit’s finding that Warhol’s Prince Series works were substantially similar to Goldsmith’s photograph, nor did it challenge the Second Circuit’s findings with respect to the other fair use factors. Instead, the limited question presented was “whether the first fair use factor, ‘the purpose and character of the use, including whether such use is of a commercial nature or is for nonprofit educational purposes,’ [17 U.S.C.] §107(1), weighs in favor of AWF’s recent commercial licensing to [Vanity Fair’s parent company].”
The Copyright Act sets forth four factors to consider when evaluating fair use:
- The purpose and character of the use, including whether such use is of a commercial nature or is for nonprofit educational purposes
- The nature of the copyrighted work
- The amount and substantiality of the portion used in relation to the copyrighted work as a whole
- The effect of the use upon the potential market for or value of the copyrighted work.
AWF argued that the Prince Series is transformative and the first fair use factor should weigh in its favor given that Warhol’s work conveys a different message than Goldsmith’s photograph, namely, one on the “dehumanizing nature of celebrity” and showing Prince as “an iconic, larger-than-life figure.” The Supreme Court, however, stressed that the first factor “considers the reasons for, and nature of, the copier’s use of an original work. The ‘central’ question it asks is ‘whether the new work merely ‘supersede[s] the objects’ of the original creation . . . (‘supplanting’ the original), or instead adds something new, with a further purpose or different character.”
In this case, the Supreme Court explained that Goldsmith’s photograph and AWF’s Orange Prince share the same purpose because they are both “portraits of Prince used to depict Prince in magazine stories about Prince.” Acknowledging that the works convey different messages or meanings, the Supreme Court reasoned that “[a]lthough new expression may be relevant to whether a copying use has a sufficiently distinct purpose or character, it is not, without more, dispositive of the first factor.”
The Supreme Court warned that an “overbroad concept of transformative use, one that includes any further purpose, or any different character, would narrow the copyright owner’s exclusive right to create derivate works,” effectively constricting the rights afforded to copyright owners in favor of a more expansive view of fair use.
The first fair use factor must assess the use of the allegedly infringing work: “If an original work and a secondary use share the same or highly similar purposes, and the secondary use is of a commercial nature, the first factor is likely to weigh against fair use, absent some other justification for copying.” In this case, the infringing use was the commercial licensing of Orange Prince. However, the Supreme Court explicitly left open the idea that had Orange Prince (or any works in the Prince Series) been used for a different purpose (e.g., “solely for teaching purposes”), the analysis would have been different. Likewise, the Supreme Court stressed that there is little to no justification for the copying because Warhol’s work does not comment on Goldsmith’s photograph and any such justification in this case is easily outweighed by the commercial nature of AWF’s use.
CONCURRENCE
Justice Gorsuch, joined by Justice Jackson, authored a concurring opinion, stressing that the focus of the first factor should be to assess the purpose and character of the challenged use, not of the work itself or the artist’s intentions: “Nothing in the copyright statute calls on judges to speculate about the purpose an artist may have in mind when working on a particular project. Nothing in the law requires judges to try their hand at art criticism and assess the aesthetic character of the resulting work.” This distinction is important because, as also highlighted by the majority, “[t]o hold otherwise would risk making a nonsense of the statutory scheme – suggesting that transformative uses of originals belong to the copyright holder (under §106) but that others may simultaneously claim those transformative uses for themselves (under §107).”
DISSENT
Justice Kagan, joined by Chief Justice Roberts, authored a fiery dissent, criticizing the majority as “hamper[ing] the creative progress and undermin[ing] creative freedom.” The dissent is particularly disheartened by (what it perceives as) the majority’s dismissal of Warhol’s “artistry and social commentary.” The dissent agrees that the effect Warhol’s work has on Goldsmith’s ability to license her photograph is relevant to the fair use analysis, just not in connection with the first factor:
That issue is no doubt important in the fair use inquiry. But it is the stuff of factor 4: how Warhol’s use affected the “value of” or “market for” Goldsmith’s photo. Factor 1 focuses on the other side of the equation: the new expression, meaning, or message that may come from someone else using the original.
The dissent further disagreed with the majority’s take on the effect this decision will have on future creative works. The majority reasons that this decision will protect copyright owners’ rights to derivative works and, therefore, incentivize the creation of new artistic works. The dissent, however, disagrees, highlighting that most—if not all—new creations in some way borrow from those of the past, and the right to use those prior works (or portions thereof) must be protected so as not to stifle creativity. The dissent’s position, as characterized by the majority, is that “Nothing comes from nothing . . . nothing ever could. . . . So somewhere in the copyright statute, there must be an ‘escape valve’ to create something good.”
Practice Note: This decision arguably narrows the scope of the fair use defense and cautions that the purpose of the secondary user’s work, particularly where such use is definitively commercial, controls the first fair use factor. This Supreme Court decision will no doubt affect future fair use inquiries as copyright-protected works continue to be used in connection with novel technologies such as artificial intelligence-generated works and non-fungible tokens, among others.

Private Markets Update | Spring 2023
ARTICLE / REPORT
Private Markets Update | Spring 2023
May 2023
Read time: 2 min
The Private Markets Update highlights developments in the European private markets, covering the issues that matter to investors in alternative assets. Touching on themes as diverse as predictions for fintech, transatlantic restructuring trends and aligning price expectations in the German Mittelstand, we review what we learned from markets shifts in 2022 and share predictions for 2023 and beyond.
